Methods of De Novo Assembly of Barcoded Genomic DNA Fragments
US-2019203204-A1 · Jul 4, 2019 · US
US11530436B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11530436-B2 |
| Application number | US-201816615872-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2018 |
| Priority date | May 23, 2017 |
| Publication date | Dec 20, 2022 |
| Grant date | Dec 20, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides a method for assembly of genomic DNA using multiplex end-tagging amplification of genomic fragments.
Opening claim text (preview).
What is claimed is: 1. A method of DNA amplification comprising contacting genomic DNA with a library of transposomes with each transposome of the library having two transposases and two transposon DNA, wherein each transposon DNA includes a transposase binding site and a primer binding site sequence, wherein the primer binding site sequence is different from the primer binding site of other members of the transposome library, and wherein each transposome within the library of transposomes includes two different primer binding site sequences, wherein the library of transposomes bind to target locations along the genomic DNA and the transposase cleaves the genomic DNA into a plurality of double stranded genomic DNA fragments representing a genomic DNA fragment library, with each double stranded genomic DNA fragment includes a unique and/or different primer binding site sequence on each end of the genomic DNA fragment, filling a gap between the transposon DNA and the genomic DNA fragment to form a library of double stranded genomic DNA fragment extension products having unique and/or different primer binding site sequences at each end, and amplifying the double stranded genomic DNA fragment extension products to produce amplicons. 2. The method of claim 1 further including sequencing the amplicons. 3. The method of claim 1 wherein the genomic DNA is whole genomic DNA obtained from a single cell. 4. The method of claim 1 wherein the transposase is Tn5 transposase, Mu transposase, Tn7 transposase or IS5 transposase. 5. The method of claim 1 wherein the transposon DNA includes a double-stranded 19 bp Tnp binding site and an overhang, wherein the overhang includes a unique and/or different primer binding site sequence at the 5′ end of the overhang. 6. The method of claim 1 wherein bound transposases are removed from the double stranded fragments before gap filling and extending of the double stranded genomic DNA fragments. 7. The method of claim 1 wherein the genomic DNA is from a prenatal cell. 8. The method of claim 1 wherein the genomic DNA is from a cancer cell. 9. The method of claim 1 wherein the genomic DNA is from a circulating tumor cell. 10. The method of claim 1 wherein the genomic DNA is from a single prenatal cell. 11. The method of claim 1 wherein the genomic DNA is from a single cancer cell. 12. The method of claim 1 wherein the genomic DNA is from a single circulating tumor cell. 13. The method of claim 1 where the genomic DNA is the product of chromatin conformation capture from a single cell or a small sample. 14. The method of claim 1 where the genomic DNA is the native or fixed chromatin from a single cell or minute amount of samples. 15. The method of claim 1 wherein the unique and different primer binding site sequence is a specific PCR primer binding site. 16. The method of claim 1 wherein the library of transposomes includes 1 to 100 unique and different primer binding site sequences. 17. The method of claim 1 wherein the library of transposomes includes 1 to 10 unique and different primer binding site sequences. 18. The method of claim 1 wherein the library of transposomes includes 5 to 50 unique and different primer binding site sequences. 19. The method of claim 1 wherein the library of transposomes includes 30 to 100 unique and different primer binding site sequences. 20. The method of claim 1 wherein the library of transposomes includes 15 to 25 unique and different primer binding site sequences. 21. The method of claim 1 wherein the library of transposomes includes 100 to 1,000 unique and different primer binding site sequences. 22. The method of claim 1 wherein the library of transposomes includes 1,000 to 10,000 unique and different primer binding site sequences. 23. The method of claim 1 wherein the library of transposomes includes 10,000 to 100,000 unique and different primer binding site sequences. 24. The method of claim 1 wherein the different primer binding site sequences are orthogonal.
Nucleic acid amplification reactions · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Recombinase · CPC title
Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors · CPC title
incorporating/generating a new priming site · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.